Hans Strid

4.5k total citations
94 papers, 3.3k citations indexed

About

Hans Strid is a scholar working on Genetics, Epidemiology and Gastroenterology. According to data from OpenAlex, Hans Strid has authored 94 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Genetics, 47 papers in Epidemiology and 36 papers in Gastroenterology. Recurrent topics in Hans Strid's work include Inflammatory Bowel Disease (60 papers), Microscopic Colitis (46 papers) and Gastrointestinal motility and disorders (33 papers). Hans Strid is often cited by papers focused on Inflammatory Bowel Disease (60 papers), Microscopic Colitis (46 papers) and Gastrointestinal motility and disorders (33 papers). Hans Strid collaborates with scholars based in Sweden, United States and United Kingdom. Hans Strid's co-authors include Magnus Simrén, Lena Öhman, Stefan Isaksson, Anders Lasson, Antal Bajor, Maria K. Magnusson, Per‐Ove Stotzer, Riadh Sadik, Iris Posserud and Henrik Sjövall and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Hans Strid

85 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hans Strid 1.4k 1.2k 1.1k 950 606 94 3.3k
Gabriele Riegler 1.6k 1.1× 768 0.7× 1.4k 1.2× 1.3k 1.3× 621 1.0× 84 3.7k
Jana G. Hashash 1.6k 1.2× 549 0.5× 1.4k 1.2× 1.1k 1.2× 515 0.8× 249 3.7k
Claudio Romano 1.0k 0.7× 955 0.8× 648 0.6× 1.3k 1.3× 739 1.2× 245 4.2k
Brigida Barberio 797 0.6× 1.2k 1.0× 630 0.6× 911 1.0× 440 0.7× 111 2.8k
Erasmo Miele 1.3k 0.9× 2.1k 1.8× 1.2k 1.1× 1.9k 2.0× 604 1.0× 193 4.8k
William R. Treem 1.2k 0.9× 721 0.6× 1.1k 0.9× 1.3k 1.3× 1.0k 1.7× 140 4.5k
Riccardo Bonfanti 1.7k 1.2× 1.5k 1.3× 1.1k 1.0× 2.2k 2.3× 518 0.9× 156 4.6k
Osvaldo Borrelli 948 0.7× 1.5k 1.3× 652 0.6× 1.7k 1.8× 507 0.8× 136 3.6k
Ron Shaoul 1.7k 1.2× 465 0.4× 1.2k 1.0× 1.2k 1.3× 523 0.9× 191 3.7k
Arne Røseth 1.7k 1.2× 414 0.4× 1.1k 1.0× 963 1.0× 573 0.9× 60 3.2k

Countries citing papers authored by Hans Strid

Since Specialization
Citations

This map shows the geographic impact of Hans Strid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Strid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Strid more than expected).

Fields of papers citing papers by Hans Strid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Strid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Strid. The network helps show where Hans Strid may publish in the future.

Co-authorship network of co-authors of Hans Strid

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Strid. A scholar is included among the top collaborators of Hans Strid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Strid. Hans Strid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Everhov, Åsa H., Michael Eberhardson, Caroline Nordenvall, et al.. (2025). Cumulative incidence and prevalence of perianal diseases in patients with inflammatory bowel disease and in the population: a nationwide Swedish study. Scandinavian Journal of Gastroenterology. 60(4). 349–354.
3.
Axelrad, Jordan E., Anders Forss, Karl Mårild, et al.. (2025). Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study. Journal of Crohn s and Colitis. 20(2).
4.
Houte, Maaike Van Den, Livia Guadagnoli, Lena Öhman, et al.. (2024). Predictors of Symptoms Trajectories in Newly Diagnosed Ulcerative Colitis: A 3-Year Follow-up Cohort Study. Journal of Crohn s and Colitis. 18(9). 1394–1405. 1 indexed citations
5.
Gils, Tom van, et al.. (2024). Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study. Alimentary Pharmacology & Therapeutics. 61(2). 268–277. 3 indexed citations
6.
Peterson, Christer, Charlotte Hedin, Daniel Bergemalm, et al.. (2024). Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD. Alimentary Pharmacology & Therapeutics. 60(6). 765–777. 7 indexed citations
7.
Eriksson, Carl, Per Karlén, Olof Grip, et al.. (2023). Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. Therapeutic Advances in Gastroenterology. 16. 1108357929–1108357929. 4 indexed citations
8.
Hedin, Charlotte, Anders Forss, Charlotte Söderman, et al.. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal. 10(7). 631–639. 29 indexed citations
9.
Eriksson, Carl, Lina Vigren, Anders Kärnell, et al.. (2021). Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. Scandinavian Journal of Gastroenterology. 56(11). 1304–1311. 6 indexed citations
10.
Eriksson, Carl, Ruzan Udumyan, Per Karlén, et al.. (2021). Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study. Therapeutic Advances in Gastroenterology. 14. 1088206362–1088206362. 19 indexed citations
11.
Eriksson, Carl, Susanna Jäghult, Jan Björk, et al.. (2018). Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scandinavian Journal of Gastroenterology. 53(10-11). 1257–1263. 8 indexed citations
12.
Lebrero‐Fernández, Cristina, Ulf Alexander Wenzel, Paulina Akéus, et al.. (2016). Altered expression of Butyrophilin ( BTN ) and BTN‐like ( BTNL ) genes in intestinal inflammation and colon cancer. Immunity Inflammation and Disease. 4(2). 191–200. 62 indexed citations
13.
Maaser, Christian, Ebbe Langholz, Hannah Gordon, et al.. (2016). European Crohn's and Colitis Organisation Topical Review on environmental factors in IBD. Journal of Crohn s and Colitis. 11(8). jjw223–jjw223. 38 indexed citations
14.
Lasson, Anders, Lena Öhman, Per‐Ove Stotzer, et al.. (2014). Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study. United European Gastroenterology Journal. 3(1). 72–79. 42 indexed citations
15.
Magnusson, Maria K., Rahil Dahlén, Hans Strid, et al.. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. United European Gastroenterology Journal. 1(6). 467–476. 11 indexed citations
16.
Strid, Hans, Magnus Simrén, Anders Lasson, et al.. (2013). Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity. Journal of Crohn s and Colitis. 7(12). e615–e622. 17 indexed citations
17.
Strid, Hans & Magnus Simrén. (2005). The effects of physical activity on the gastrointestinal tract : review article. International sportmed journal for FIMS. 6(3). 151–161. 1 indexed citations
18.
Strid, Hans, et al.. (2004). Delay in gastric emptying in patients with chronic renal failure. Scandinavian Journal of Gastroenterology. 39(6). 516–520. 61 indexed citations
19.
Niklasson, Anna, et al.. (2003). Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases. Respiratory Medicine. 97(10). 1143–1150. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriele Riegler Breakdown of academic impact, for papers by Jana G. Hashash Breakdown of academic impact, for papers by Claudio Romano Breakdown of academic impact, for papers by Brigida Barberio Breakdown of academic impact, for papers by Erasmo Miele Breakdown of academic impact, for papers by William R. Treem Breakdown of academic impact, for papers by Riccardo Bonfanti Breakdown of academic impact, for papers by Osvaldo Borrelli Breakdown of academic impact, for papers by Ron Shaoul Breakdown of academic impact, for papers by Arne Røseth
Rankless by CCL
2026